Multiple sclerosis: Cytokine receptors on oligodendrocytes predict innate regulation
- 5 November 2003
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 55 (1) , 46-57
Abstract
Multiple sclerosis (MS) is an immune‐mediated demyelinating condition in which numerous soluble mediators have been implicated. We have extended the repertoire of cytokines studied in MS tissue by examining interleukin (IL‐4), IL‐6, IL‐10, IL‐12, IL‐18, interferon (IFNγ), and their receptors and have compared patterns with those seen in normal subjects and other neurological diseases (OND). Expression was evaluated by immunocytochemistry and Western blots. Remarkably, oligodendrocytes expressed all the cytokine receptors examined, particularly Th2‐type, constitutively in normal subjects and upregulated in disease. Microglial cells also expressed cytokine receptors at similar levels. Cytokine expression was invariably a feature of microglial cells, except for IL‐10, which was exclusively astrocytic. Oligodendrocytes did not display cytokines, except for low levels of IL‐18. Although no pattern was specific for MS, most molecules were upregulated in MS and OND. Downstream JAK/STAT molecules were correspondingly upregulated. Cytokine receptors on oligodendrocytes (and microglia), and their corresponding ligands on microglia (and astrocytes), may implicate paracrine/autocrine regulation and may bespeak innate immunity in the central nervous system.Keywords
This publication has 40 references indexed in Scilit:
- Interleukin-12 and the regulation of innate resistance and adaptive immunityNature Reviews Immunology, 2003
- Interleukin-18Journal of Leukocyte Biology, 2003
- lnterleukin-10 in the BrainCritical Reviews in Immunology, 2001
- Neuregulins and erbB receptor expression in adult human oligodendrocytesGlia, 2000
- Interleukin 6 and its Receptor: Ten Years LaterInternational Reviews of Immunology, 1998
- Functional diversity of helper T lymphocytesNature, 1996
- Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions.Journal of Experimental Medicine, 1995
- Cloning of a new cytokine that induces IFN-γ production by T cellsNature, 1995
- Interleukin 4 receptor: signaling mechanismsImmunology Today, 1994
- Anti—tumor necrosis factor therapy abrogates autoimmune demyelinationAnnals of Neurology, 1991